Centiva Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-34,041
Closed -$304K 1658
2023
Q3
$304K Buy
+34,041
New +$304K 0.01% 749